Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
Hospital stocks plummet as SC threatens price controls     Back
(01 Mar 2024)
Max Healthcare sank 7.12%, leading the pack of decliners which included Krishna Institute of Medical Sciences (down 5.89%), Global Health (down 3.84%), Aster DM Healthcare (down 2.11%), Fortis Healthcare (down 1.71%), Kovai Medical Center & Hospital (down 1.62%), Narayana Hrudayalaya (down 1.48%), Apollo Hospitals Enterprise (down 0.67%), Rainbow Children's Medicare (down 0.64%) and Shalby (down 0.26%) tumbled. This follows earlier losses of 2-6.5% during the previous session.

The Supreme Court's stance stems from its criticism of the government's inaction on regulating hospital charges and enforcing existing rules. It has directed the government to develop a standardised rate plan within a month, or it might enforce rates applicable to government-empanelled hospitals, which are significantly lower than what private hospitals typically charge.

Investors fear this potential change in pricing will negatively impact the revenue of hospital chains. A domestic broker highlighted the strong opposition this proposal is likely to face due to lower Central Government Health Scheme (CGHS) rates, uneven implementation of regulations (Clinical Establishment Act) across states, and the complexity of standardising costs given varying factors like treatment needs, individual health conditions, and hospital services.

Top